Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Muscle-specific ER-associated degradation maintains postnatal muscle hypertrophy and systemic energy metabolism
Benedict Abdon, Yusheng Liang, Débora da Luz Scheffer, Mauricio Torres, Neha Shrestha, Rachel B. Reinert, You Lu, Brent Pederson, Amara Bugarin-Lapuz, Sander Kersten, Ling Qi
Benedict Abdon, Yusheng Liang, Débora da Luz Scheffer, Mauricio Torres, Neha Shrestha, Rachel B. Reinert, You Lu, Brent Pederson, Amara Bugarin-Lapuz, Sander Kersten, Ling Qi
View: Text | PDF
Research Article Cell biology Muscle biology

Muscle-specific ER-associated degradation maintains postnatal muscle hypertrophy and systemic energy metabolism

  • Text
  • PDF
Abstract

The growth of skeletal muscle relies on a delicate equilibrium between protein synthesis and degradation; however, how proteostasis is managed in the endoplasmic reticulum (ER) is largely unknown. Here, we report that the SEL1L-HRD1 ER-associated degradation (ERAD) complex, the primary molecular machinery that degrades misfolded proteins in the ER, is vital to maintain postnatal muscle growth and systemic energy balance. Myocyte-specific SEL1L deletion blunts the hypertrophic phase of muscle growth, resulting in a net zero gain of muscle mass during this developmental period and a 30% reduction in overall body growth. In addition, myocyte-specific SEL1L deletion triggered a systemic reprogramming of metabolism characterized by improved glucose sensitivity, enhanced beigeing of adipocytes, and resistance to diet-induced obesity. These effects were partially mediated by the upregulation of the myokine FGF21. These findings highlight the pivotal role of SEL1L-HRD1 ERAD activity in skeletal myocytes for postnatal muscle growth, and its physiological integration in maintaining whole-body energy balance.

Authors

Benedict Abdon, Yusheng Liang, Débora da Luz Scheffer, Mauricio Torres, Neha Shrestha, Rachel B. Reinert, You Lu, Brent Pederson, Amara Bugarin-Lapuz, Sander Kersten, Ling Qi

×

Figure 3

Postnatal hypertrophic growth of skeletal muscle requires SEL1L-HRD1 ERAD.

Options: View larger image (or click on image) Download as PowerPoint
Postnatal hypertrophic growth of skeletal muscle requires SEL1L-HRD1 ERA...
(A) Representative photos of hindlimb skeletal muscle tissue in mice at 4 and 12 weeks old. (B) Comparison of glycolytic (gastrocnemius, tibialis anterior, EDL) and oxidative muscle (soleus) mass of 4- and 12-week-old male mice (n = 6 per genotype/time point). (C) Representative H&E staining of tibialis anterior muscle in 4- and 12-week-old mice (n = 6 mice per genotype). (D) Representative confocal image of laminin staining of 8-week-old tibialis anterior muscle (n = 4 mice per genotype). (E) Frequency distribution of muscle cross-sectional area of 4- and 12-week-old tibialis anterior muscle with quantitation (n = 6 mice per genotype/time point, ~100–200 fibers per mouse). (F) Fiber type analysis of myosin heavy chain (MyHC) subtypes, type I (red), type IIa (blue), type IIx (unstained/black), and type IIb (green), with laminin staining the myofiber membrane (n = 5–6 mice per genotype). (G) Quantitation of fiber type percentage of tibialis anterior muscle from 8-week-old mice (n = 5–6 mice per genotype). (H) Body mass curves of male and female Ire1αfl/fl and Ire1αMLC mice (n = 4–28 per genotype/sex/time point). (I) Comparison of glycolytic (quadriceps, gastrocnemius, tibialis anterior [T.A.], EDL) and oxidative muscle (soleus [SOL]) mass of 15-week-old male mice (n = 3 mice per genotype). Data presented as mean ± SEM. NS, P > 0.05; *P < 0.05; **P < 0.01; ****P < 0.0001 determined by 2-way ANOVA with Tukey’s multiple-comparison test (B and E), 2-tailed, unpaired t test (G and I), or mixed-effects analysis (repeated-measure ANOVA) (H).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts